Apollo Commercial Real Estate Finance (ARI): Q2 2026 Results Strengthen the Liquidation Case

Apollo Commercial Real Estate Finance (NYSE: ARI) reported its second-quarter 2026 results on August 10, and the numbers confirm that the company has undergone a fundamental transformation.

ARI has now sold essentially its entire commercial real estate loan portfolio to Athene for approximately $8.6 billion, repaid its secured financing and senior debt, and ended June with $1.24 billion of cash and approximately $857 million of net real estate owned (REO) assets. There were no commercial mortgage loans remaining at June 30.

For Q2, ARI reported:

- Net income: $25.8 million

- Net income available to common shareholders: $22.7 million

- GAAP EPS: $0.11

- Distributable Earnings: -$2.62/share

- Distributable Earnings excluding realized investment/debt-extinguishment losses: $0.15/share

- Total net revenue: $44.4 million

- Cash: $1.239 billion

- Common shares outstanding: 128.2 million as of August 7.

The negative $2.62 Distributable Earnings figure is largely a consequence of the realized losses associated with the loan-portfolio sale and debt extinguishment and therefore should not be interpreted as evidence that the remaining liquidation assets are worth only $6.50 per share. ARI itself says Distributable Earnings should not be considered a substitute for GAAP net income or a measure of liquidity.

For investors, the more important question remains the liquidation value.

ARI's preliminary proxy estimates $7.75–$8.50 per share of future liquidating distributions, excluding the $3.75 distribution already paid in July. Including that July payment, the estimated total value returned is $11.50–$12.25/share, assuming liquidation by the first half of 2028.

With ARI recently trading around $6.50–$6.61, the liquidation thesis remains attractive, although there are several important risks.

1. Q2 2026 marks the end of the old ARI

The most important Q2 development isn't the $0.11 EPS.

It is what happened to the balance sheet.

On April 24, 2026, ARI completed the sale of its commercial real estate loan portfolio to Athene for approximately $8.6 billion. The transaction represented approximately 99.7% of the total commitment amount of the loans included in the sale.

The proceeds were used to repay essentially all of ARI's major corporate financing.

By June 30:

- Secured debt arrangements: $0

- Senior secured term loans: $0

- Senior secured notes: $0

- Commercial mortgage loans: $0

- Cash and equivalents: $1.239 billion

- REO assets, net: $857.0 million

- Total assets: $2.136 billion

- Total liabilities: $881.4 million.

This is a dramatic change from December 31, 2025, when ARI had approximately $8.77 billion of net loans and almost $8.0 billion of liabilities. The company is therefore no longer primarily a leveraged commercial mortgage REIT.

It is now essentially:«Cash + real estate assets − remaining liabilities = liquidation value.»

2. The Q2 balance sheet is much easier to understand

The June 30 balance sheet looks like this:

Item| June 30, 2026

Cash & equivalents| $1.239B

REO, net| $857M

Other assets| $40M

Total assets| $2.136B

Remaining REO debt| $371M

Other liabilities| $510M

Total liabilities| $881M

Stockholders' equity| $1.255B

The company had 128.2 million common shares outstanding as of August 7.

There is an important accounting point here.

The $1.255 billion total equity includes the Series B-1 preferred stock, which had a $169.3 million liquidation preference at June 30. ARI subsequently redeemed all Series B-1 preferred shares on July 15 at $25 per share plus accrued dividends. No preferred shares remain outstanding.

Therefore, the June 30 common-equity value after deducting the preferred liquidation preference was approximately:

$1.255B − $169M = ~$1.086B

or approximately: $8.47 per common share using 128.2 million shares.

This is an important reference point, but it should not be confused with the company's projected liquidation value of $11.50–$12.25 including the July distribution. The liquidation estimate incorporates expected future cash flows, asset sales and other adjustments and is calculated on a fully diluted basis.

3. Q2 earnings: $0.11 EPS looks better than it really is

ARI reported: $0.11 GAAP EPS versus $0.12 in Q2 2025.

Net income available to common shareholders was $22.7 million.

At first glance, this looks reasonably healthy.

But it isn't particularly meaningful anymore.

Q2 included several large items related to the liquidation:

- $379.2M CECL allowance release

- $339.1M net realized loss on investments

- $30.7M loss on extinguishment of debt

- $18.9M foreign-currency translation gain

- $36.2M revenue from REO operations.

The net result was $25.8 million of GAAP net income.

This accounting volatility is exactly why I would not value ARI using P/E or quarterly EPS.

The company's own press release emphasizes that Distributable Earnings is not a GAAP liquidity measure and that its calculation excludes certain realized and unrealized items.

4. Distributable Earnings of -$2.62 looks terrible — but needs context

ARI reported: Q2 Distributable Earnings: $2.62/share

However:

Distributable Earnings before net realized investment and debt-extinguishment losses: +$0.15/share.

The negative figure is therefore heavily distorted by the extraordinary realization of losses associated with the portfolio sale and debt repayment.

During the first half of 2026, ARI recorded approximately $339.1 million of net realized investment losses. The company explains that the bulk related to the loan-portfolio transaction, including the write-off of previously recorded CECL allowances.

This is not something I would extrapolate into the future.

There is effectively no loan portfolio left against which to generate recurring interest income.

Therefore: «Q2 distributable earnings are not a useful measure of ARI's future earning power.»

The liquidation value is much more important.

5. The $3.75 dividend: Q2 confirms the transition

ARI's Q2 filing shows a $3.75/share dividend declared for the quarter, compared with $0.25 in Q2 2025.

The $3.75 was paid on July 15, 2026 to shareholders of record as of June 30.

But investors should not expect ARI to resume its old quarterly dividend.

The Q2 release still contains the standard REIT language stating that ARI generally intends to pay dividends corresponding to taxable income if authorized by the board. However, the company is simultaneously pursuing complete liquidation, and its proxy explicitly contemplates liquidating distributions rather than a normal recurring dividend stream.

Therefore:

I would assume no regular quarterly dividend going forward.

Future payments could occur, but they are expected to come from the liquidation process as ARI sells assets and settles liabilities. That distinction is critical.

6. What remains after the loan sale?

At June 30, ARI's remaining assets were predominantly:

Cash: $1.239B

This is the safest component of the balance sheet and represents substantial liquidity after the debt repayment.

REO: $857M

This is now the main source of uncertainty.

ARI owns real estate acquired through foreclosures and deed-in-lieu transactions. The properties include hotels and other commercial real estate.

Unlike cash, the $857 million carrying value does not guarantee an equivalent amount of cash proceeds.

Actual sales prices could be higher or lower.

ARI's accounting for REO uses fair-value estimates involving market, income and cost approaches, with significant unobservable inputs. Therefore, actual liquidation proceeds remain uncertain.

This is the biggest risk in the investment.

7. The $7.75–$8.50 liquidation estimate remains the key number

The Q2 filing itself does not replace the liquidation estimate published in the proxy.

ARI's current estimate is:

Future liquidating distributions: $7.75–$8.50/share

July 15 distribution: $3.75/share

Total estimated value returned: $11.50–$12.25/share

The company assumes a complete liquidation by H1 2028.

Importantly, the $7.75–$8.50 is the relevant figure for someone buying ARI after the July distribution.

8. At $6.50, the valuation becomes interesting

Using the $6.50 share price:

Future liquidation recovery| Return from $6.50

$6.00| -7.7%

$6.50| 0%

$7.00| +7.7%

$7.75| +19.2%

$8.125 midpoint| +25.0%

$8.50| +30.8%

This is the most attractive aspect of the current situation.

The market price is below even the low end of management's estimated remaining distribution range. However, there is a very important caveat:

ARI's estimate was prepared using information available as of July 9, 2026, and the company explicitly warns that actual distributions may differ materially. It also states that the estimate does not incorporate subsequent changes in interest rates, markets or other conditions.

9. One new risk revealed by Q2: share count

The liquidation estimate was based on 130.764 million fully diluted shares as of July 9.

The actual common shares outstanding were 128.212 million as of August 7.

This is actually favorable from a per-share liquidation perspective if the lower share count persists.

However, ARI warns that additional shares could be issued in connection with management compensation and accelerated equity awards. The final per-share distribution will therefore depend on the eventual fully diluted share count. This is something I would monitor closely in every subsequent filing.

10. Timeline after Q2

April 24, 2026

ARI completed the approximately $8.6B loan-portfolio sale to Athene.

June 30, 2026

Q2 balance-sheet date.

At this point ARI had:

- $1.239B cash

- $857M REO

- no commercial mortgage loans

- no secured corporate debt.

July 15, 2026

ARI paid the $3.75/share distribution.

The Series B-1 preferred stock was also fully redeemed at $25 plus accrued dividends.

August 10, 2026

ARI released Q2 results.

The company confirmed the post-sale balance sheet and the absence of the old loan portfolio.

2026–2027

The company intends to monetize its remaining REO assets and make additional liquidating distributions.

The timing and amount of these payments are not fixed.

H1 2028

ARI's current liquidation assumptions contemplate substantially completing the liquidation during the first half of 2028. The company explicitly warns that actual completion could take longer.

11. What I would watch next

For ARI investors, the next quarterly report will be much more important for the balance sheet than for EPS.

I would focus on five things:

1. REO carrying value vs. actual sale prices

This is the biggest determinant of the final recovery.

2. Cash balance

Cash should rise as properties are sold, although some proceeds will be consumed by liabilities and liquidation costs.

3. Remaining liabilities

The lower the remaining liabilities, the greater the ultimate common-stock recovery.

4. Fully diluted share count

Every additional share reduces the liquidation proceeds per share.

5. Updated liquidation estimate

This is the single most important number.

If ARI maintains or raises the $7.75–$8.50 estimated future distribution range while the stock remains around $6.50, the investment case becomes stronger.

If the estimate is reduced materially, the market could react sharply.

Conclusion: Q2 makes ARI look more like a liquidation arbitrage

The Q2 results do not change my fundamental view of ARI.

They reinforce it.

The company has now completed the most important step: selling the $8.6 billion commercial loan portfolio and eliminating essentially all of its secured corporate debt. At June 30, ARI held approximately $1.24 billion of cash and $857 million of REO assets against $881 million of total liabilities.

The $0.11 GAAP EPS is not particularly important, and the -$2.62 Distributable Earnings should not be interpreted as a deterioration in the remaining liquidation value. The negative number is dominated by realized losses connected with the portfolio sale and debt extinguishment.

The critical figure remains the company's estimated $7.75–$8.50 of future liquidating distributions, excluding the $3.75 already paid.

At a share price of approximately $6.50, this represents potential nominal upside of approximately 19% at the low end, 25% at the midpoint and 31% at the high end.

My rating: SPECULATIVE BUY

I consider ARI considerably more interesting around $6.50 than it was at $7.50.

But this is not a dividend stock anymore.

Investors should not buy ARI expecting another predictable quarterly $0.25 dividend. Future payments are expected to come primarily through irregular liquidating distributions as ARI sells its remaining assets and winds down the company. The company has not established a fixed timetable for those payments.

The principal risk is straightforward: «The $7.75–$8.50 estimated recovery is an estimate, not cash in the bank.»

The $1.24 billion cash balance provides meaningful protection, but approximately $857 million of remaining REO assets still have to be monetized, while the company has approximately $881 million of total liabilities. Actual sale proceeds, expenses, taxes, litigation and other obligations will determine how much ultimately reaches common shareholders.

For me, the key investment equation is therefore:

$6.50 purchase price → $7.75–$8.50 estimated remaining distributions → potential 19–31% nominal return → target liquidation H1 2028.

The next major catalyst is the shareholder vote on the dissolution plan and, even more importantly, evidence that ARI can sell its REO portfolio close to carrying values.

If the next reports show asset sales at or above book value while the estimated liquidation distribution remains around $7.75–$8.50, I would become increasingly constructive on ARI.The article is now based primarily on ARI's August 10 Q2 2026 10-Q and its official Q2 earnings release, rather than secondary commentary. The SEC filing is especially useful because it gives us the actual post-transaction balance sheet and the current share count.